In addition, the NKG2D polymorphism also affects the responsiveness of RA patients to TNF inhibitors, and patients with the rs2255336 or rs1049174 heterozygous genotypes have a better European League Against Rheumatism (EULAR) response than those with homozygous genotypes [74]. This evidence concerns the gene KLRK1 and rheumatoid arthritis.